Beclomethasone, formoterol and glycopyrronium: effect on an ex vivo model of COPD exacerbation

L. Calzetta (Rome, Italy), B. Ritondo (Rome, Italy), F. Cavalli (Rome, Italy), M. Matino (Rome, Italy), M. Cazzola (Rome, Italy), P. Rogliani (Rome, Italy)

Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Session: Scientific advances in airway pharmacology
Session type: E-poster session
Number: 3305
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Calzetta (Rome, Italy), B. Ritondo (Rome, Italy), F. Cavalli (Rome, Italy), M. Matino (Rome, Italy), M. Cazzola (Rome, Italy), P. Rogliani (Rome, Italy). Beclomethasone, formoterol and glycopyrronium: effect on an ex vivo model of COPD exacerbation. 3305

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Beclomethasone, formoterol and glycopyrronium: synergy of dual and triple combinations in an ex vivo model of COPD exacerbation
Source: Virtual Congress 2021 – Pharmacology of airway diseases: clinical and laboratory studies
Year: 2021


Beclomethasone, formoterol and glycopyrronium: ceiling effect in small airways of COPD patients
Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Year: 2020




Synergistic interaction between beclomethasone diproprionate and formoterol fumarate in an ex vivo model of bronchial asthma
Source: International Congress 2018 – Basic pharmacology
Year: 2018

Beclomethasone, formoterol and glycopyrronium: synergism of triple therapy on human airways
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019

Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 386s
Year: 2002

Addition of formoterol Turbuhaler® to budesonide Turbuhaler® increases the time to first severe exacerbation in long-term treatment of mild asthma: results from OPTIMA
Source: Eur Respir J 2001; 18: Suppl. 33, 517s
Year: 2001

Formoterol (Modulite), tiotropium and their combination in patients with acute exacerbation of chronic bronchitis: preliminary data
Source: Eur Respir J 2005; 26: Suppl. 49, 285s
Year: 2005

Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone
Source: Eur Respir J 2001; 18: 262-268
Year: 2001



Comparison of fluticasone, roflumilast and tiotropium in a model of influenza-induced acute COPD exacerbation
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013

Budesonide and formoterol in mild persistent asthma compared with doubling the dose of budesonide - a cost-effectiveness analysis
Source: Eur Respir J 2001; 18: Suppl. 33, 517s
Year: 2001

The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 212s
Year: 2006

Nebulized formoterol improves airway function in COPD subjects receiving maintenance tiotropium
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008

Effect of ICS/LABA combination in an ex vivo model of COPD exacerbation
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020


Effects of procaterol or salmeterol added to maintenance tiotropium therapy on small airway functions in COPD patients
Source: Annual Congress 2010 - COPD: management
Year: 2010


Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma
Source: Eur Respir J 2007; 29: 682-689
Year: 2007



Assessment of long-term effects of combined extra-fine beclomethasone and formoterol treatment in asthma patients using functional imaging
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010


Comparison of a combination of tiotropium and formoterol to salmeterol and fluticasone in moderate COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 14s
Year: 2005

Tiotropium + olodaterol provides significant lung-function benefits compared to fluticasone + salmeterol regardless of prior bronchodilator use
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016


The effects of treatment with fluticasone propionate alone and combination with salmeterol on asthma control and airway inflammation
Source: Eur Respir J 2003; 22: Suppl. 45, 287s
Year: 2003

The effect of fluticasone vs fluticasone plus salmeterol on allergen-induced bronchial inflammation in asthmatic patients. A long-term RCT
Source: Eur Respir J 2004; 24: Suppl. 48, 125s
Year: 2004